← All companies
Twist Bioscience Corp
TWST - CIK 0001581280
Market cap$4.22 B
Rank#1523
SEC filings1,496
The table below shows Twist Bioscience Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | $185.57M | $179.63M | $155.38M | $119.33M | $80.62M | $61.41M |
| Gross profit | - | - | - | - | - | - |
| R&D | $80.28M | $90.85M | $106.89M | $120.31M | $69.07M | $43.01M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.